Di Maio, M., Daniele, G. and Piccirillo, M. 2013. Impact on health-related quality of life of the addition of bevacizumab to first-line chemotherapy for ovarian cancer:  . Cancer Breaking News. 1, 1 (Oct. 2013), 33–35.